Not Hepatorenal Syndrome: Fibrillary Glomerulonephritis Despite Virologic Cure of Hepatitis C (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0714; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Given the poor renal prognosis of FGN, early consideration of kidney biopsy is essential. Rituximab has shown variable success, with better outcomes reported when initiated early before significant fibrosis develops.This case underscores the need for continued vigilance for glomerular disease in patients with HCV, even after viral clearance."
Diabetes • Diabetic Nephropathy • Fibrosis • Glomerulonephritis • Hepatitis C • Hepatology • Immunology • Infectious Disease • Inflammation • Lupus Nephritis • Metabolic Disorders • Nephrology • Renal Disease • Type 2 Diabetes Mellitus
|
|
Iktimal Alwan; Mahmoud H. Abdalla; Asha Ramsakal; Jason Rothschild
|